Zebra Capital Management LLC Travere Therapeutics, Inc. Transaction History

Zebra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $136,874 - $263,941	-10,545 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $16,071 - $30,069	-1,139 Reduced 9.75%	10,545 $154,000
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $755,505 - $1.03 Million	-32,328 Reduced 73.45%	11,684 $292,000
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $843,710 - $1.23 Million	44,012 New	44,012 $1.2 Million

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.